Davies Collison Cave boasts an industry leading team that head professional bodies, provide high-level government advice and have proven records as respected advocates.
B.Sc. (Advanced) (Hons.), Ph.D., Patent Attorney
Since joining Davies Collison Cave in 2006, Andrew has enjoyed the challenge of preparing and prosecuting patent applications for inventions conceived both locally and abroad in the fields of organic chemistry, medicinal chemistry and polymer chemistry. Andrew has gained exposure to a wide range of technologies from cheese processing to monoclonal antibody therapeutics and from implantable devices to low calorie beer production. Andrew has also been involved in opposition proceedings and in the enforcement of patent rights.
Andrew's Doctoral thesis described a novel, modular, stereoselective total synthesis of the antimitotic natural product (-)-podophyllotoxin. Biological evaluation of a range of novel diasteromeric model systems assisted in evaluating the most potent stereochemical configuration of synthetic analogs of (-)-podophyllotoxin and its semi-synthetic anti-cancer derivatives etoposide and teniposide.
Andrew went on to gain post-doctoral experience investigating the potential for the stabilisation of complex High Internal Phase Emulsion (HIPE) systems using novel, polymeric amphiphilic molecules. During his post-doctoral studies Andrew utilised Controlled Radical Polymerisation (CRP) techniques such as Reversible Addition-Fragmentation Chain-Transfer (RAFT) polymerisation.
In a decision currently under appeal, the Federal Court has once again highlighted the importance of identifying “the… more »
Ramon Tozer and Andrew Scott attended the 32nd APS held in Coffs Harbour, NSW. The symposium offered a varied program which… more »
June 30th – July 2nd The International Nanomedicine Conference held on beautiful Coogee Beach attracted 200… more »